Location: Room 342, Dirksen Senate Office BuildingOpen in New Window
The Subcommittee held two days of hearings to examine the extent to which consumers can purchase pharmaceuticals over the Internet without a medical prescription, the importation of pharmaceuticals into the United States, and whether the pharmaceuticals from foreign sources are counterfeit, expired, unsafe, or illegitimate. This first hearing, held on June 17th examined the extent to which U.S. consumers can purchase dangerous and often addictive controlled substances from Internet pharmacy websites and the procedures utilized by the Food and Drug Administration, the Drug Enforcement Administration, the Bureau of Customs and Border Protection, and private stakeholders to address these drug safety issues. The second hearing on this issue was held on July 22nd.
This webcast is an audio only stream.
Dr. Marcia CrosseDownload Testimony (853k)Director, Public Health and Military Health Care IssuesU. S. Government Accountability Office
Mr. Robert J. CramerDownload Testimony (83k)Managing Director, Office of Special InvestigationsGeneral Accounting OfficeWashington, DC
The Honorable Rudolph W. GiulianiDownload Testimony (116k)Chairman and CEOGiuliani Partners, LLC
Dr. Marvin D. ShepherdDownload Testimony (1939k)Director, Center for Pharmacoeconomic StudiesCollege of Pharmacy, University of Texas at AustinAustin, Texas
Ms. Francine HaightDownload Testimony (53.2 KB)Lost Son to Illegal Prescription Drugs PurchasedThrough Domestic Internet CompaniesOrange County, California
Ms. Elizabeth CarrDownload Testimony (41 KB)Lost Husband to Illegal Prescription Drugs PurchasedThrough International Internet CompaniesSacramento, California